Prevalence of Rhipicephalus sanguineus infestation and Babesia canis infection in dogs with respect to breed type and degree of freedom in Makurdi, Benue State-Nigeria
The Internet Journal of Parasitic Diseases · 2010
DOI: 10.5580/2497 ↗At a glance
Journal article in The Internet Journal of Parasitic Diseases, 2010. Cited 2 times so far (Crossref).
Abstract (original language)
An investigation on the prevalence of Rhipicephalus sanguineus infestation and Babesia canis infection among domestic dogs in Makurdi metropolis was carried out. The blood samples were collected from the tip of the ear of randomly selected 108 dogs; thin blood smears were stained with Giemsa stain and then examined under the microscope. Stereoscopic examination was used for the identification of ticks collected. 11 (10.2%) dogs were found positive for babesiosis, male dogs recorded an infection rate of 13.8% while female had 6.0%. No significant difference was observed between male and female dogs(X =2.59, P > 0.05). A total of 89(82.4%) dogs were found to be infested with ticks mainly Rhipicephalus sanguineus. With regards to the degree of restriction, infection among free-roaming, semi-confined and confined dogs was significantly different (X =1.32, p
Cite
APA
(2010). Prevalence of Rhipicephalus sanguineus infestation and Babesia canis infection in dogs with respect to breed type and degree of freedom in Makurdi, Benue State-Nigeria. The Internet Journal of Parasitic Diseases. https://doi.org/10.5580/2497
Vancouver
Prevalence of Rhipicephalus sanguineus infestation and Babesia canis infection in dogs with respect to breed type and degree of freedom in Makurdi, Benue State-Nigeria. The Internet Journal of Parasitic Diseases. 2010. doi:10.5580/2497
BibTeX
@article{euvimed2010,
title = {Prevalence of Rhipicephalus sanguineus infestation and Babesia canis infection in dogs with respect to breed type and degree of freedom in Makurdi, Benue State-Nigeria},
journal = {The Internet Journal of Parasitic Diseases},
year = {2010},
doi = {10.5580/2497}
}
EUVIMED